DARE
Dare Bioscience, Inc.Company with tickers: DARE
CIK
1401914
CUSIP
23666P200
Shares Outstanding
14,979,502
13F Activity (30d)
21 filings
21 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $152,455 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | $242,325 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Gross Profit | — | ||||
| Operating Expenses | $2,909,028 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $660,462 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-2,998,898 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-2,999,889 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.21 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.21 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |